M. Helena Azevedo

Suggest Changes
Learn More
BACKGROUND Genetic aberrations in various components of cAMP signalling pathway predispose to endocrine tumours. Mutations in the phosphodiesterases (PDEs) are involved in the predisposition to(More)
Therapy with dopamine agonists has been associated with valvular heart disease (VHD) in Parkinson’s disease, raising concern about the safety of these drugs. In hyperprolactinemic patients, the(More)